We are analyzing https://link.springer.com/article/10.1007/s11912-002-0059-2.

Title:
Discovery of cancer preventive agents from natural products: From plants to prevention | Current Oncology Reports
Description:
Cancer chemoprevention has traditionally been defined as a dietary or therapeutic approach for the prevention, delay, or reversal of carcinogenesis. We currently expand this definition to include nontoxic applications for patients with established disease. In this context, efficacy can be achieved by selectively altering cell-cycle progression. In the quest for new cancer chemopreventive agents, we have focused on the isolation of natural products as lead molecules, followed by synthetic modification to improve activity. Using biologic response as a guide for fractionation, over 200 active compounds have been identified. Some of the most interesting include brassinin and 4′-bromoflavone as inducers of quinone reductase, deguelin as an inhibitor of ornithine decarboxylase, resveratrol as an inhibitor of cyclooxygenase, and brusatol as an inducer of cellular differentiation. These agents have demonstrated effectiveness in experimental models of carcinogenesis. Further development of these agents as chemopreventive drugs may proceed through the normal regulatory process (eg, 4′-bromoflavone). Alternatively, some natural products may be administered as dietary supplements (eg, resveratrol). In either case, chemoprevention offers great hope in reducing the morbidity and mortality associated with cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Science
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, google, scholar, pubmed, cas, article, chemopreventive, chemoprevention, res, prevention, natural, agents, mehta, products, activity, resveratrol, research, pezzuto, carcinogenesis, breast, sci, privacy, cookies, content, ornithine, decarboxylase, cell, mammary, product, data, publish, search, discovery, plants, phd, dietary, inhibitor, access, review, eur, cells, agent, natl, chem, lee, gerhäuser, information, log, journal, bromoflavone,

Topics {✒️}

month download article/chapter glutathione s-transferases biomarkers anti-tumor promoting diterpenes azoxymethane-treated mouse colon 20-epi-vitamin d3 analogues natural product derived full article pdf prostate cancer prevention privacy choices/manage cookies specific irreversible inhibitor mehta phd & john mehta rg occupational epidemiology research cancer chemopreventive activity article mehta preneoplastic mammary lesions structurally related isothiocyanates cancer chemopreventive agents cancer chemopreventive potential ornithine decarboxylase induction mammary tumor models sporn mb kong a-nt european economic area include nontoxic applications normal regulatory process masso-welch pa decreased ovarian hormones monomethylated selenium metabolite harwood academic publishers 1alpha-hydroxyvitamin d5 naturally occuring rotenoid future perspective provided chemoprevention working group linking environmental cancer conditions privacy policy bhat kpl kosmeder jw ii cancer preventive agents related subjects anticarcinogenic agent natural products seminal paper helped breast cancer prevention activity guided fractionation activity-guided isolation apoptosis inducing agents accepting optional cookies article log interesting include brassinin

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Discovery of cancer preventive agents from natural products: From plants to prevention
         description:Cancer chemoprevention has traditionally been defined as a dietary or therapeutic approach for the prevention, delay, or reversal of carcinogenesis. We currently expand this definition to include nontoxic applications for patients with established disease. In this context, efficacy can be achieved by selectively altering cell-cycle progression. In the quest for new cancer chemopreventive agents, we have focused on the isolation of natural products as lead molecules, followed by synthetic modification to improve activity. Using biologic response as a guide for fractionation, over 200 active compounds have been identified. Some of the most interesting include brassinin and 4′-bromoflavone as inducers of quinone reductase, deguelin as an inhibitor of ornithine decarboxylase, resveratrol as an inhibitor of cyclooxygenase, and brusatol as an inducer of cellular differentiation. These agents have demonstrated effectiveness in experimental models of carcinogenesis. Further development of these agents as chemopreventive drugs may proceed through the normal regulatory process (eg, 4′-bromoflavone). Alternatively, some natural products may be administered as dietary supplements (eg, resveratrol). In either case, chemoprevention offers great hope in reducing the morbidity and mortality associated with cancer.
         datePublished:
         dateModified:
         pageStart:478
         pageEnd:486
         sameAs:https://doi.org/10.1007/s11912-002-0059-2
         keywords:
            Resveratrol
            DMBA
            Ornithine Decarboxylase
            Chemopreventive Agent
            Sulforaphane
            Oncology
         image:
         isPartOf:
            name:Current Oncology Reports
            issn:
               1534-6269
               1523-3790
            volumeNumber:4
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Current Medicine Group
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rajendra G. Mehta
               affiliation:
                     name:College of Pharmacy, University of Illinois at Chicago
                     address:
                        name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John M. Pezzuto
               affiliation:
                     name:College of Pharmacy, University of Illinois at Chicago
                     address:
                        name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Discovery of cancer preventive agents from natural products: From plants to prevention
      description:Cancer chemoprevention has traditionally been defined as a dietary or therapeutic approach for the prevention, delay, or reversal of carcinogenesis. We currently expand this definition to include nontoxic applications for patients with established disease. In this context, efficacy can be achieved by selectively altering cell-cycle progression. In the quest for new cancer chemopreventive agents, we have focused on the isolation of natural products as lead molecules, followed by synthetic modification to improve activity. Using biologic response as a guide for fractionation, over 200 active compounds have been identified. Some of the most interesting include brassinin and 4′-bromoflavone as inducers of quinone reductase, deguelin as an inhibitor of ornithine decarboxylase, resveratrol as an inhibitor of cyclooxygenase, and brusatol as an inducer of cellular differentiation. These agents have demonstrated effectiveness in experimental models of carcinogenesis. Further development of these agents as chemopreventive drugs may proceed through the normal regulatory process (eg, 4′-bromoflavone). Alternatively, some natural products may be administered as dietary supplements (eg, resveratrol). In either case, chemoprevention offers great hope in reducing the morbidity and mortality associated with cancer.
      datePublished:
      dateModified:
      pageStart:478
      pageEnd:486
      sameAs:https://doi.org/10.1007/s11912-002-0059-2
      keywords:
         Resveratrol
         DMBA
         Ornithine Decarboxylase
         Chemopreventive Agent
         Sulforaphane
         Oncology
      image:
      isPartOf:
         name:Current Oncology Reports
         issn:
            1534-6269
            1523-3790
         volumeNumber:4
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Current Medicine Group
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rajendra G. Mehta
            affiliation:
                  name:College of Pharmacy, University of Illinois at Chicago
                  address:
                     name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John M. Pezzuto
            affiliation:
                  name:College of Pharmacy, University of Illinois at Chicago
                  address:
                     name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Oncology Reports
      issn:
         1534-6269
         1523-3790
      volumeNumber:4
Organization:
      name:Current Medicine Group
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:College of Pharmacy, University of Illinois at Chicago
      address:
         name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
         type:PostalAddress
      name:College of Pharmacy, University of Illinois at Chicago
      address:
         name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rajendra G. Mehta
      affiliation:
            name:College of Pharmacy, University of Illinois at Chicago
            address:
               name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      name:John M. Pezzuto
      affiliation:
            name:College of Pharmacy, University of Illinois at Chicago
            address:
               name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
      name:Department of Medicinal Chemistry and Pharmacognosy (MC 877), College of Pharmacy, University of Illinois at Chicago, Chicago, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(137)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.78s.

LINK . SPRINGER . COM {}